Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07AD01	CLOBEVAT	G	Clobetasol (propionate) - 0.05%	0.05%	Cream	302,045 L.L
D07AD01	CLOBEVAT	G	Clobetasol (propionate) - 0.05%	0.05%	Ointment	302,045 L.L
B05XA01	CHLORURE DE POTASSIUM PROAMP	G	Potassium chloride - 0.0746g/ml	0.0746g/ml	Injectable concentrated solution	1,252,461 L.L
S01GX09	CONJYCLEAR	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	510,660 L.L
G01AF02	CANESTEN	B	Clotrimazole - 0.1g	0.1g	Tablet	408,528 L.L
J01MA02	CIPROX	G	Ciprofloxacine (lactate) - 200mg/100ml	0.2%w/v	Injectable solution	520,067 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
C02AC05	CYNT	B	Moxonidine - 0.2mg	0.2mg	Tablet, film coated	853,639 L.L
C02AC05	CYNT	B	Moxonidine - 0.3mg	0.3mg	Tablet, film coated	1,153,162 L.L
C02AC05	CYNT	B	Moxonidine - 0.4mg	0.4mg	Tablet, film coated	1,153,162 L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	26,710,896 L.L
R06AE09	CALIVIDA	G	Levocetirizine dihydrochloride - 0.5mg/ml	0.5mg/ml	Solution	1,158,264 L.L
R03BA02	CORTAIR	G	Budesonide - 1mg/2ml	0.5mg/ml	Inhalation suspension for nebuliser	1,209,458 L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	36,110,993 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	1,104,639 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	705,517 L.L
B05XA03	CHLORURE DE SODIUM 0.9 pour cent Renaudin	G	Sodium chloride - 0.9%	0.9%	Injectable solution	385,683 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
N01BB02	CHLORHYDRATE DE LIDOCAINE RENAUDIN	G	Lidocaine (HCl) - 10mg/ml	1%	Injectable solution	591,291 L.L
D06BX01	CUTIDERMINE	G	Metronidazole - 1%	1%	Gel	593,850 L.L
M02AA15	CLOFEN	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Creamagel	210,983 L.L
J01XB01	COLIXIN	G	Colistimethate Sodium - 1,000,000IU	1,000,000IU	Injectable powder for solution, Inhalation powder	20,296,042 L.L
J01DE01	CEFIPEX 1000 BENTA	G	Cefepime - 1,000mg	1,000mg	Injectable dry powder+diluent	703,918 L.L
J01DE01	CEFIPEX 1000 BENTA	G	Cefepime (hydrochloride) - 1,000mg	1,000mg	Injectable solution	703,918 L.L
J01XB01	COLISTIMETHATE SODIQUE PANPHARMA	G	Colistimethate Sodium - 1.000.000IU	1.000.000IU	Injectable powder for solution, Inhalation powder	6,392,659 L.L